Status:
COMPLETED
Effect of Genotyping for CYP450 Polymorphisms Versus Intense Clinical Monitoring on Antipsychotic Drug Treatment
Lead Sponsor:
Gesche Jurgens
Collaborating Sponsors:
Bispebjerg Hospital
Research Unit, Psyciatric Centre Bispebjerg
Conditions:
Schizophrenia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether genotyping for CYP2D6 and 2C19 polymorphisms or intense clinical monitoring of treatment and adverse effects improves the antipsychotic treatment in p...
Eligibility Criteria
Inclusion
- Diagnosed with schizophrenia
- Able to give written informed consent
Exclusion
- Genotyped prior to inclusion
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
311 Patients enrolled
Trial Details
Trial ID
NCT00707382
Start Date
February 1 2008
End Date
December 1 2011
Last Update
February 10 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Clinical Pharmacology, Bispebjerg Hospital and Research Unit, Psychiatric Centre Bispebjerg
Copenhagen, Denmark, 2400